Celecoxib may be safe and effective for the treatment of acute migraine and migraine-associated symptoms among patients with episodic migraine.
In a systematic review and meta-analysis, researchers sought to compare outcomes associated with the use of lasmiditan, rimegepant, and ubrogepant vs triptans for the acute management of migraine headaches.
Researchers conducted a study to assess the effect of galcanezumab on the total pain burden of patients with episodic cluster headache.
Individuals without a migraine history have increased odds of achieving CMH, although the association is attenuated after adjustment for physical health and mental health problems.
Patients report increased depressive symptomatology in the migraine headache phase of a migraine attack.
Patients with migraine without prior clinical care have reduced GMV in the right dMPFC compared to those with prior care.
Choroidal vascularity index, and RNFL thickness in all quadrants except nasal were significantly reduced in study participants with migraine.
Osmophobia is prevalent among patients with different migraine subtypes, and it also occurs in some patients with tension-type headaches.
Migraine is associated with an increased risk for all-cause dementia and Alzheimer disease, according to research published online.
A history of migraine prior to pregnancy is associated with anxiety and with mixed depression and anxiety in mid-pregnancy and late pregnancy.